Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Hwudarw Chen"'
Autor:
Natalia A. Ignatenko, Jennifer K. Barton, David G. Besselsen, Raymond B. Nagle, Edward R. Abril, Chiu-Hsieh Hsu, Hwudarw Chen, Mykella S. Jones, Kevin G. Ehrichs, Photini F.S. Rice
Supplementary Table 1. Statistical analysis of endpoints derived from histology. Number of animals in different groups is listed in Figure 1B. Supplementary Table 2. Statistical analysis of adenoma grade by genotypes in the subset of AOM-induced mice
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::900123c2a40b6cd2dc97795afee6e000
https://doi.org/10.1158/1940-6207.22534889.v1
https://doi.org/10.1158/1940-6207.22534889.v1
Autor:
Natalia A. Ignatenko, Jennifer K. Barton, David G. Besselsen, Raymond B. Nagle, Edward R. Abril, Chiu-Hsieh Hsu, Hwudarw Chen, Mykella S. Jones, Kevin G. Ehrichs, Photini F.S. Rice
The NSAID sulindac has been successfully used alone or in combination with other agents to suppress colon tumorigenesis in patients with genetic predisposition and also showed its efficacy in prevention of sporadic colon adenomas. At the same time, s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::625d1b42be390a9a1d88c028ef1968e5
https://doi.org/10.1158/1940-6207.c.6547691.v1
https://doi.org/10.1158/1940-6207.c.6547691.v1
Autor:
Photini F. S. Rice, Raymond B. Nagle, Mykella S. Jones, Jennifer K. Barton, Edward R. Abril, Chiu Hsieh Hsu, Hwudarw Chen, David G. Besselsen, Kevin G. Ehrichs, Natalia A. Ignatenko
Publikováno v:
Cancer Prevention Research. 11:16-26
The NSAID sulindac has been successfully used alone or in combination with other agents to suppress colon tumorigenesis in patients with genetic predisposition and also showed its efficacy in prevention of sporadic colon adenomas. At the same time, s
Autor:
Photini F S, Rice, Kevin G, Ehrichs, Mykella S, Jones, Hwudarw, Chen, Chiu-Hsieh, Hsu, Edward R, Abril, Raymond B, Nagle, David G, Besselsen, Jennifer K, Barton, Natalia A, Ignatenko
Publikováno v:
Cancer Prev Res (Phila)
The non-steroidal anti-inflammatory drug (NSAID) Sulindac has been successfully used alone or in combination with other agents to suppress colon tumorigenesis in patients with genetic predisposition, and also showed its efficacy in prevention of spor